Dual antiplatelet therapy for secondary prevention of coronary artery disease

Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y(12) receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) for stable coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales: Degrauwe, Sophie, Pilgrim, Thomas, Aminian, Adel, Noble, Stephane, Meier, Pascal, Iglesias, Juan F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652612/
https://www.ncbi.nlm.nih.gov/pubmed/29081979
http://dx.doi.org/10.1136/openhrt-2017-000651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652612/
https://www.ncbi.nlm.nih.gov/pubmed/29081979
http://dx.doi.org/10.1136/openhrt-2017-000651

Ejemplares similares